Patrick Ott, MD, PhD | Authors

Articles

Current and Emerging Immunotherapeutic Strategies in Melanoma

January 03, 2018

Patrick Ott, MD, PhD, clinical director, Melanoma Center, Center for Immuno-Oncology, physician, assistant professor of medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses current and emerging immunotherapeutic strategies in melanoma.